Skip to content
Congress·In Committee·9 months ago

House Bill Would Pay Drugmakers to Stockpile 6-Month Supply of Critical Medicines

Also known as: RAPID Reserve Act

Legislative Progress

✓ Filed
Review
House
Senate
President

Impacts

Positive Impacts(1)
Chronic Illness
Helps

Key Points

  • HHS would pay selected drugmakers and suppliers to keep a rolling reserve of certain “critical” medicines and their key ingredients.
  • Companies in the program would generally keep about a 6-month backup supply, and replace it regularly with newly made product so it doesn’t get too old.
  • In a shortage or emergency, HHS could direct companies to ramp up production and could direct where some ingredient supplies go to help other manufacturers.
  • The bill aims to reduce the risk of drug shortages caused by problems like too few factories, quality issues, or too much production in one region.
  • Congress would allow up to $500 million for 2026 to run the program; HHS would publish the drug list and report to Congress every 2 years.
HealthcarePrescription Drugs

Milestones

2 milestones2 actions
Jun 12, 2025House

Referred to the House Committee on Energy and Commerce.

Jun 12, 2025

Introduced in House

What Happens Next

Projected impacts based on AI analysis

After the law takes effect; timing not specified in the bill

HHS publishes a list of “critical” drugs and their active ingredients covered by the program

People who use those medicines (and the hospitals that need them) are the most likely to see fewer shortages once reserves are built

After the law takes effect; likely within the first year if funded

HHS starts awarding contracts/cooperative agreements to manufacturers and partners

Selected companies begin setting up storage, testing, and “rolling” replacement of inventory; this is when the reserve starts becoming real

No later than 6 months after the law is enacted

Within 180 days of enactment, HHS and the Food and Drug Administration issue program guidance

This guidance will spell out how drugs are chosen, what quality/capacity companies must show, and how much extra capacity/reserve they must maintain

As contracts take effect; could take months to a year depending on the drug

Companies build and maintain a 6‑month (or similar) rolling reserve of ingredients and finished drugs

Over time, pharmacies and hospitals should have better backup supply during disruptions, reducing canceled treatments or forced substitutions

Only when an emergency/disaster/threat occurs

During a public health emergency or disaster, HHS can direct where reserved ingredients are allocated

Areas hit hardest could get medicine faster, but some routine customers may see product rerouted temporarily

2 years after the first contract/cooperative agreement is awarded

Two years after the first award, HHS submits the first effectiveness report to Congress (and then every two years)

This can lead to changes in which drugs are covered, how strict the reserve rules are, and how much funding Congress provides later

Related News

4 articles
Becker's Hospital Review·9 months ago

Senate bill aims to rebuild drug manufacturing infrastructure: 3 notes

Bipartisan senators reintroduced the RAPID Reserve Act to address generic drug shortages by expanding domestic stockpiles and manufacturing capacity. The bill requires HHS to award contracts to U.S. or allied manufacturers to maintain reserves of essential medications and ingredients.

C=
Fierce Pharma·9 months ago

Senators bring back bill to bolster US pharma supply chain by awarding contracts to domestic producers

The Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act would require HHS to issue contracts to U.S.-based or OECD-based drugmakers to maintain reserves of critical medications and key ingredients, aiming to reduce overreliance on China and improve preparedness.

C=
RealClearDefense·about 1 month ago

Pharmaceutical Blackout: The Hidden Threat to U.S. Security

Authors argue that the RAPID Reserve Act is a 'legislative lifeline' designed to prevent 'pharmacological blackouts' by bringing critical medicine manufacturing back to U.S. shores and building strategic reserves of generic drugs currently dependent on Chinese and Indian supply chains.

CR+

Source Information

Document Type

Congressional Bill

Official Title

RAPID Reserve Act

Bill NumberHR 3955
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the House Committee on Energy and Commerce.

Sponsor

Cosponsors

(1)
R: 1

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.